PenderFund Capital Management is one of BC’s Best Workplaces

PenderFund Capital Management is one of BC's Best Workplaces GlobeNewswire October 31, 2025 VANCOUVER,  British Columbia, Oct. 31, 2025 (GLOBE NEWSWIRE) — PenderFund Capital Management Ltd. (“Pender”) is delighted to announce that it has been named on the 2025 Best Workplaces in BC list. This honour was bestowed on Pender after thorough, independent analysis undertaken […]

Protect Your Investment: Contact Levi & Korsinsky About the Tvardi Therapeutics, Inc. (TVRD) Investigation

NEW YORK, NY / ACCESS Newswire / October 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Tvardi Therapeutics, Inc. ("Tvardi Therapeutics, Inc.") (NASDAQ:TVRD) concerning possible violations of federal securities laws. On October 13, 2025, Tvardi reported data from its Phase 2 REVERT study testing its STAT3 inhibitor drug,

ATTENTION VRNS Shareholders: Lost Money on Varonis Systems, Inc.? Contact Levi & Korsinsky About Investigation

NEW YORK, NY / ACCESS Newswire / October 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Varonis Systems, Inc. ("Varonis Systems, Inc.") (NASDAQ:VRNS) concerning possible violations of federal securities laws. On October 28, 2025, Varonis reported third quarter fiscal 2025 revenue below estimates on the back of weaker

Investigation Alert: Zions Bancorporation, National Association (ZION) Under Scrutiny – Contact Levi & Korsinsky for Details

NEW YORK, NY / ACCESS Newswire / October 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zions Bancorporation, National Association ("Zions Bancorporation, National Association") (NASDAQ:ZION) concerning possible violations of federal securities laws. Bloomberg published a report on October 16, 2025, titled, "Zions, Western Alliance Banks Disclose Bad Loans

Fujitsu to provide digital ticketing service for NTT DOCOMO's new d ticket platform

Fujitsu today announced that it will provide its digital ticketing service to NTT DOCOMO [1] for its new ticket platform service, d ticket, which launched in Japan on October 31, 2025. The new service builds on the success of NTT DOCOMO's smart ticketing service, which leverages Fujitsu's service for digital ticket sales and management, launched

SERES Net Profit for First Three Quarters Hits 5.312 Billion RMB, to Be the First Luxury NEV Maker with “A+H” Listing

On October 30,SERES released its financial results for the third quarter of 2025. According to the report, SERES generated revenue of 110.534 billion RMB and net profit attributable to shareholders of 5.312 billion RMB in the first three quarters, with a YoY growth of 31.56%. https://mma.prnewswire.com/media/2810268/AITO_Product_Lineup.jpg AITO Product Line Continues to Expand; AITO M9 Sets

Ongoing Investigation: Arcturus Therapeutics Holdings Inc. (ARCT) May Have Misled Shareholders – Levi & Korsinsky Investigates

NEW YORK, NY / ACCESS Newswire / October 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Arcturus Therapeutics Holdings Inc. ("Arcturus Therapeutics Holdings Inc.") (NASDAQ:ARCT) concerning possible violations of federal securities laws. Arcturus issued a press release on October 22, 2025, "announc[ing] interim results from its ongoing Phase

LRN Investor Notice: Levi & Korsinsky Investigates Stride, Inc. for Securities Law Violations

NEW YORK, NY / ACCESS Newswire / October 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Stride, Inc. ("Stride, Inc.") (NYSE:LRN) concerning possible violations of federal securities laws. On October 28, 2025, Stride reported its first quarter fiscal 2026 earnings after market. While earnings beat expectations, enrollment numbers

Levi & Korsinsky Investigates Alector, Inc. (ALEC) Over Possible Securities Fraud

NEW YORK, NY / ACCESS Newswire / October 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Alector, Inc. ("Alector, Inc.") (NASDAQ:ALEC) concerning possible violations of federal securities laws. On October 22, 2025, Alector announced results from its Phase 2 INFRONT-3 clinical trial evaluating latozinemab (AL001) in patients with

CTA Construction Managers Completes Fire Safety Training Building at Taunton Public Safety Complex

CTA Construction Managers recently completed construction on the new Fire Safety Training Building in Taunton, MA. CTA Construction Managers is pleased to announce the completion of the new Fire Safety Training Building at the Taunton Public Safety Complex, marking a significant milestone in the City of Taunton's ongoing investment in public safety infrastructure. The newly

Scroll to Top